Er, but the case study you linked is very different. There they're talking about getting specific tailored treatment right the first time. Here we're talking

Er, but the case study you linked is very different. There they're talking about getting specific tailored treatment right the first time. Here we're talking about getting a generic reusable component right the first time. Which is exactly what that link advocates against...